Please login to the form below

Not currently logged in
Email:
Password:

migraines

This page shows the latest migraines news and features for those working in and with pharma, biotech and healthcare.

Allergan gets FDA nod for first oral CGRP drug for migraine

Allergan gets FDA nod for first oral CGRP drug for migraine

head of the FDA’s Office of Neuroscience, who notes that there are around 37m people in the US who suffer from migraines. ... 1F. agonists for acute migraine which was approved in the US in October.

Latest news

More from news
Approximately 24 fully matching, plus 143 partially matching documents found.

Latest Intelligence

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    Published adherence in migraine-prophylaxis (as a comparable indication) indicates 92.6% adherent at one month, 40.7% at two months, 30.9% at three months, 24.8% at four months,

  • Deal Watch January 2018

    Teva’s CGRP patent portfolio to develop, manufacture and commercialise eptinezumab, its phase III CGRP antibody for the treatment of migraine.  In exchange for the licence, Alder will withdraw its appeal

  • The good, the bad and the ugly The good, the bad and the ugly

    Three CGRP monoclonal antibodies will launch in the US for migraine in 2018 - with a fourth anticipated in 2019.

  • The cultural construction of illness The cultural construction of illness

    Some years ago, we were asked to advise on marketing a cure for migraines in the UK. ... In this world, migraines were associated with ideas of the overly sensitive, or even hysterical woman, requiring rational male intervention to bring her back to her

  • Ditch the data? Ditch the data?

    Around one in seven people suffer from migraines, and these can impact severely on quality-of-life. ... When a migraine hits, she needs to shut herself in a dark room in silence.

More from intelligence
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics